La violencia contra las mujeres en la Universidad de El Salvador. . 23

The development of technology for the production of potential nutriments through the isolation of enzymes and genetic engineering enables large-scale production of compounds that were previ- ously rare and diffi cult to obtain in suffi cient quantity at a reasonable cost. More and more health- promoting compounds could be produced by genetic engineering technology. However, at present, consumers tend to dislike products that have been produced by genetically modifi ed organisms (GMO), particularly in the European Union and Japan.

Continuous efforts to establish the safety of products produced by GMO aim to gain consum- ers’ understanding and acceptance of nutriments produced by genetic engineering. We hope that nutriments produced by genetically engineered bacteria will be launched onto the market and will contribute to the health and wealth of the people of the world.

Orotic acid Glucose C. ammoniagenes UMP E. coli cki pyrG cct UDP UTP UTP CTP UTP PRPP PPi ATP ADP ATP ADP

Cells are permeabilized by an organic solvent

Choline P-choline CDP-choline

REFERENCES

Alvarez, X.A., Laredo, M, Corzo, D., et al., 1997. Citicoline improves memory performance in elderly subjects.

Methods Find. Exp. Clin. Pharmacol. 19: 201–210.

Amenta, F., Parnetti, L., Gallai, V., and Wallin, A., 2001. Treatment of cognitive dysfunction associated with Alzheimer’s disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?

Mech. Ageing Develop. 122: 2025–2040.

Baldwin, J.E., Field, R.A., Lawrence, C.C., Merritt, K.D., and Schofi eld, C.J., 1993. Proline 4-hydroxylase: Stereochemical course of the reaction. Tetrahedron Lett. 34: 7489–7492.

Burjanadze, T.V. and Veis, A., 1997. A thermodynamic analysis of the contribution of hydroxyproline to the structural stability of the collagen triple helix. Connective Tissue Res. 36: 347–365.

Burk, R.F., 1983. Glutathione-dependent protection by rat liver microsomal protein against lipid peroxidation.

Biochim. Biophys. Acta 757: 21–28.

Chance, B., Sies, H., and Boveris, A., 1979. Hyperoxide metabolism in mammalian organs. Physiol. Rev. 59: 527–605.

Chasseaud, L.F., 1979. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res. 29: 175–274.

Deng, M.-D., Grund, A.D., Wassink, S.L., et al., 2006a. Directed evolution and characterization of Escherichia

coli glucosamine synthase. Biochimie 88: 419–429.

Deng, M.-D., Severson, D.K., Grund, A.D., et al., 2005. Metabolic engineering of Escherichia coli for indus- trial production of glucosamine and N-acetylglucosamine. Metab. Eng. 7: 201–214.

Deng, M.-D., Wassink, S.L., and Grund, A.D., 2006b. Engineering a new pathway for N-acetylglucosamine production: Coupling a catabolic enzyme, glucosamine-6-phosphate deaminase, with a biosynthetic enzyme, glucosamine-6-phosphate N-acetyltransferase, Enz. Microb. Technol. 39: 828–834.

Dixon, C.E., Ma, X., and Marion, D.W., 1997. Effects of CDP-choline treatment on neurobehavioral defi cits after TBI and on hippocampal and neocortical acetylcholine release. J. Neurotrauma 14: 161–169. Fujio, T. and Maruyama, A., 1997. Enzymatic production of pyrimidine nucleotides using Corynebacterium

ammoniagenes cells and recombinant Escherichia coli cells: Enzymatic production of CDP-choline from

orotic acid and choline chloride (Part I). Biosci. Biotechnol. Biochem. 61: 956–959.

Fujio, T., Teshiba, S., and Maruyama, A., 1997. Construction of a plasmid carrying both CTP synthetase and a fused gene formed from cholinephosphate cytidylyltransferase and choline kinase genes and its applica- tion to industrial CDP-choline production: Enzymatic production of CDP-choline from orotic acid (Part II). Biosci. Biotechnol. Biochem. 61: 960–964.

Galperin, M.Y. and Koonin, E.V., 1997. A diverse superfamily of enzymes with ATP-dependent carboxylate- amine/thiol ligase activity. Protein Sci. 6: 2639–2643.

Gushima, H., Miya, T., Murata, K., and Kimura, A., 1983. Construction of glutathione-producing strains of

Escherichia coli B by recombinant DNA techniques. J. Appl. Biochem. 5: 43–52.

Hungerford, D.S. and Jones, L.C. 2003. Glucosamine and chondroitin sulfate are effective in the management of osteoarthritis. J. Arthroplasty 18: 5–9.

Katz, E., Prockop, D.J., and Udenfriend, S., 1962. Precursors of the hydroxyproline and ketoproline in actino- mycin. J. Biol. Chem. 237: 1585–1588.

Kawabe, H., Nakano, T., Inui, K., and Waki, K., 2009. Composition and method for reducing allergen. US Patent application US2009/0069413.

Kajimoto, O., Odanaka, W., Sakamoto, W., Yoshida, K., and Takahashi, T., 2001. Clinical effects of foods containing hyaluronic acid on dry skin. J. New Remedies Clinics 50: 548–560.

Kumar, D. and Bhalla, T., 2005. Microbial proteases in peptide synthesis: Approaches and applications. Appl.

Microbiol. Biotechnol. 68: 726–736.

Lawrence, C.C., Sobey, W.J., Field, R.A., Baldwin, J.E., and Schofi eld, C.J., 1996. Purifi cation and initial characterization of proline 4-hydroxylase from Streptomyces griseoviridis P8648: A 2-oxoacid, ferrous- dependent dioxygenase involved in etamycin biosynthesis. Biochem. J. 313: 185–191.

Li, Y., Hugenholtz, J., Sybesma, W., Abee, T., and Molenaar, D., 2005. Using Lactococcus lactis for glutathione overproduction. Appl. Microbiol. Biotechnol. 67: 83–90.

Lopez-Coviella, I., Agut, J., Savci, V., Ortiz, J.A., and Wurtman, R.J., 1995. Evidence that 5′-cytidinediphos- pho-choline can affects brain phospholipid composition by increasing choline and cytidine plasma level.

J. Neurochem. 65: 889–894.

Meister, A. and Anderson, M.E., 1983. Glutathione. Annu. Rev. Biochem. 52: 711–760.

Murata, K. and Kimura, A., 1982. Some properties of glutathione biosynthesis-defi cient mutants of Escherichia

Murata, K. and Kimura, A., 1990. Overproduction of glutathione and its derivatives by genetically engineered microbial cells. Biotechnol. Adv. 8: 59–96.

Murata, K., Miya, T., Gushima, H., and Kimura, A., 1983. Cloning and amplifi cation of a gene for glutathione synthetase in Escherichia coli B. Agric. Biol. Chem. 47: 1381–1383.

Murata, K., Tani, K., Kato, J., and Chibata, I.., 1981. Glutathione production by immobilized Saccharomyces

cerevisiae cells containing an ATP generation system. Eur. J. Appl. Microbiol. Biotechnol. 11: 72–77.

Ohtake, Y., Watanabe, K., Tezuka, H., et al., 1988. The expression of gamma-glutamylcysteine synthetase gene of Escherichia coli in Saccharomyces cerevisiae. Agric. Biol. Chem. 52: 2753–2762.

Ohtake, Y., Watanabe, K., Tezuka, H. et al., 1989. Expression of glutathione synthetase gene of Escherichia coli B in Saccharomyces cerevisiae. J. Ferment. Bioeng. 68: 390–399.

Onishi, M., Okumura, Y., Okamoto, R., and Ishikura, T., 1984. Proline hydroxylation by cell free extract of a streptomycete. Biochem. Biophys. Res. Commun. 120: 45–51.

O’Regan, M., Martini, I., Crescenzi, F., DeLuca, C., and Lansing, M., 1994. Molecular mechanisms and genet- ics of hyaluronan biosynthesis. Int. J. Biol. Macromol. 16: 283–286.

Puhl, W. and Scharf, P., 1997. Intra-articular hyaluronan treatment for osteoarthritis. Ann. Rheum. Dis. 56: 637–640.

Richman, P.G. and Meister, A., 1975. Regulation of gamma-glutamylcysteine synthetase by nonallosteric feed- back inhibition by glutathione. J. Biol. Chem. 250: 1422–1426.

Satoh, H., Sakamoto, W., Odanaka, W., Yoshida, K., and Urushihata, O., 2002. Clinical effects of foods contain- ing hyaluronic acid on dry and rough skin. Aesthetic Dermatol. 12: 109–120.

Secades, J.J. and Frontera, G., 1995. CDP-choline: Pharmacological and clinical review. Methods Find. Exp.

Clin. Pharmacol. 17: 1–54.

Sheehan, J.C., Zachau, H.G., and Lawson, W.B., 1958. The structure of etamycin. J. Am. Chem. Soc. 80: 3349–3355.

Shibasaki, T., Mori, H., Chiba, S., and Ozaki, A., 1999. Microbial proline 4-hydroxylase screening and gene cloning. Appl. Environ. Microbiol. 65: 4028–4031.

Shibasaki, T., Mori, H., and Ozaki, A., 2000. Enzymatic production of trans-4-hydroxy-l-proline by regio- and stereospecifi c hydroxylation of l-proline. Biosci. Biotechnol. Biochem. 64: 746–750.

Tabata, K. and Hashimoto, S., 2007. Fermentative production of l-alanyl–l-glutamine by a metabolically engineered Escherichia coli strain expressing l-amino acid α-ligase. Appl. Environ. Microbiol. 73: 6378–6385.

Tabata, K., Ikeda, H., and Hashimoto, S., 2005. ywfE in Bacillus subtilis codes for a new enzyme, l-amino acid ligase. J. Bacteriol. 187: 5195–5202.

Towheed, T.E., 2003. Current status of glucosamine therapy in osteoarthritis. Arthritis Rheum. 49: 601–604. Trovarelli, G., de Medio, G.E., Dorman, R.V., Piccinin, G.L., Horrocks, L.A., and Porcellati, G., 1981. Effect pf

cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil.

Neurochem. Res. 6: 821–833.

Widner, B., Behr, R., Dollen, S.V., et al., 2005. Hyaluronic acid production in Bacillus subtilis. Appl. Environ.

Microbiol. 71: 3747–3752.

Yagasaki, M. and Hashimoto, S., 2008. Synthesis and application of dipeptides; current status and perspectives.

Appl. Microbiol. Biotechnol. 81: 13–22.

Yokota, A., Shimizu, H., Terasawa, Y., Takaoka, N., and Tomita, F., 1994. Pyruvic acid production by a lipoic acid auxotroph of Escherichia coli W1485. Appl. Microbiol. Biotechnol. 41: 638–643.

139

10

Recent Advances in

the Development of